Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global intracranial aneurysm market is set to flourish in the global market at a promising CAGR of 8.8% between 2022 and 2032. The market is anticipated to reach USD 2.56 Billion by 2032, while it holds a market value of USD 1.2 Billion in 2022.
Latest technological developments, increasing cases of brain aneurysms & their complications along with the introduction of minimally invasive procedures are gaining traction in the intracranial aneurysm market.
A global study on the intracranial aneurysm market explains that the growing cases of intracranial aneurysms in the brain involve the bulging in the wall of an artery in the brain. It causes swelling, ballooning, and widening. Aneurysms weaken the walls and make it hard for the nerves to function properly.
Intracranial aneurysms and their rising cases are attributed to the growing number of geriatric patients, fueling intracranial aneurysm treatment and solutions. The weak walls are usually thin and make no difference in the support provided by these layers, fueling the demand for intracranial aneurysm solutions and treatment.
The expanding intracranial aneurysm market size is attributed to the new advanced technology integrated with intracranial aneurysm treatment and solutions. As the risk of walls bursting increases, end-user patients, and treatment centers adopt the intracranial aneurysm treatment and solution methods.
The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions.
Attributes | Value |
---|---|
Intracranial Aneurysm Market Size (2022) | US$ 1.2 Billion |
Intracranial Aneurysm Market Projected Size (2032) | US$ 2.56 Billion |
Intracranial Aneurysm Market Value CAGR (2022 to 2032) | 8.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising high-blood pressure patients through trauma and blood vessels along with hypertension leading to the cases of an intracranial brain aneurysm are fueling the demand for intracranial aneurysm treatment and solutions.
According to the intracranial aneurysm market survey, the market is dynamic in nature and functions in every component. Currently, a large number of people are at risk of a brain aneurysm. The elderly class is more affected and exposed to the condition and seeks instant treatment solutions. From medication to consultancy, the government is focusing more and more on intracranial aneurysm treatment as it grows among the population. Minimally invasive surgeries are also helping patients in getting relief, fueling the demand for intracranial aneurysm treatment solutions.
New technology and innovative techniques like endovascular coiling are being used for the treatment of intracranial aneurysms that are a part of minimally invasive procedures, widely recommended by physicians. In this procedure, a microcatheter is inserted in the groin area through the artery consisting of an aneurysm. That checks upon the condition of the aneurysm and prevents the blood from entering other parts of the brain. This fuels the sales of intracranial aneurysm treatment solutions.
The spread of covid-19, high health risk chances during surgeries coupled with the high cost associated with treatment solutions are hindering the growth of the intracranial aneurysm market.
As the covid-19 has stretched its roots and damaged the supply chains of multiple markets, especially with the government putting bans and logistics restrictions, capital generation went low while the expense got high with time, damaging multiple market spaces.
The intracranial aneurysm market was also got adversely affected by the curse of the pandemic as the healthcare centers were filled with the covid-19 patients, and research and development centers were inactive, especially those that research minimally invasive surgeries and their effects. Another factor that hampered the growth of the intracranial aneurysm market is the risk associated with surgeries along with alternative medicine options that end user or patient considers less risky.
Intracranial aneurysm Market:
Attributes | Intracranial aneurysm Market |
---|---|
CAGR (2022 to 2032) | 8.8% |
Market Value (2022) | US$ 1.2 Billion |
Growth Factor | The growing cases of brain aneurysms in the elderly class along with advanced technological developments in minimally invasive surgeries are fueling the demand for intracranial aneurysm treatment solutions. |
Future Opportunities | New innovative techniques like endovascular techniques to monitor the condition and prevention of clotting and blood flow in other parts of the brain are creating new opportunities |
Market Trends | The latest trends in the intracranial aneurysm market are the high risks involved and the growing cases in first-world countries that are shaping the market dynamics. |
Brain Implants Market:
Attributes | Brain Implants Market |
---|---|
CAGR (2022 to 2032) | 12.1% |
Market Value (2022) | US$ 5.72 Billion |
Growth Factor | Post-lockdown surgeries due to lockdown, higher cases of a brain tumors or clotting along with the latest technology growing and fueling the demand for brain implants. |
Future Opportunities | The latest technology such as nanotechnology used in the production and research and development procedures is creating opportunities for the brain implants market. |
Market Trends | The latest market trends involve the exciting price range of these implants with the discounted installation charges shaping the market trends for the brain implants market. |
Blood Clot Retrieval Devices Market:
Attributes | Blood Clot Retrieval Devices Market |
---|---|
CAGR (2022 to 2032) | 14.5% |
Market Value (2022) | US$ 1.49 Billion |
Growth Factor | The rise in the health conditions such as a transient ischemic attacks, hemorrhagic stroke, and ischemia along with the latest technological advancements are fueling the demand for brain clotting retrieval devices. |
Future Opportunities | The opportunities that the market creates are through the addition of new stroke-specific devices, reducing the number of side effects of operative periods. |
Market Trends | The higher number of neurological and cardiac disorders consumes the most blood clotting retrieval and treatment devices, setting up upward trends for the market. |
The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the Internet of Things (IoT) is integrating with treatment solutions. Countries such as the USA, the UK, and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the USA develop an unruptured intracranial aneurysm. It is also reported that every year, around 30,000 deaths in the USA are due to the rupture of intracranial aneurysms. This pushes the demand for intracranial aneurysm treatment solutions.
According to the intracranial aneurysm market analysis, the type category has three major segments, Surgical Clipping, Endovascular Coiling, and Flow Diverters. The endovascular coiling segment dominates the market while holding a market share of 85.3% of the global share.
The minimally invasive techniques go through the catheter to locate the aneurysm in the brain. Growing hypertension among the geriatric population leads people to a higher chance of brain aneurysms and other diseases, ultimately gaining traction for the intracranial aneurysm market. The neurology industry and the Intracranial Aneurysm solutions market grow side by side, thriving the demand for Intracranial aneurysms.
According to the intracranial aneurysm market research report, the end user category is dominated by the hospital segment, holding 89.5% of the global market. The segment grows at a promising CAGR of 8.9% through the forecast period. The factors that attribute to the growth of the intracranial aneurysm market in this segment are the application of technologically advanced tools in operation theaters and intensive care units, the rising number of hospitals globally, and increased government funding to the hospitals. This fuels the sales of intracranial aneurysm treatment solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
North America holds 27% of the global share in the global intracranial aneurysm market in 2022.
The growing intracranial aneurysm market in the North American region is attributed to the growing healthcare facilities, government investments, and rising cases of brain aneurysms. Furthermore, the relevant cases of hypertension and intracranial aneurysms have increased the overall demand for intracranial aneurysm treatment solutions in new regions of North America.
Also, an increasing number of initiatives being undertaken by various organizations is expected to fuel market growth. The new research and development centers are focusing on new treatment approaches, such as the endovascular process.
Asia Pacific region is anticipated to thrive at the highest CAGR of 12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.
The cases of hypertension and brain aneurysms rising with the geriatric population growing in the region are fueling the growth of the market. Other factors that gain traction for the intracranial aneurysm market are an increasing number of initiatives being undertaken by various organizations that are expected to fuel market growth.
The Intracranial aneurysm market size expands the new diseases, and the markets related to their treatment and cure are proliferating. Higher government investments and businesses are taking an interest in the specific healthcare support centers, along with the rising healthcare sector in almost every region, which is increasing the startup activity.
The non-profitable organization is also taking part in building these health centers. For instance, The Bee Foundation (TBF), an NGO, is focusing on spreading awareness and reducing the number of deaths due to cerebral aneurysms through innovative research.
The intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market.
The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson Services Inc., Microvention Inc., Codman Neuro (Integra Lifesciences).
Recent Developments in the Global Intracranial Aneurysm Market
The intracranial aneurysm market is expected to grow at 8.8% CAGR from 2022 to 2032.
The Intracranial aneurysm market is estimated to be around US$ 1.2 Billion in 2022.
The intracranial aneurysm market is anticipated to reach a revenue of US$ 2.56 Billion by 2032.
The Endovascular Coiling segment is forecasted to hold the largest market share by type category in the intracranial aneurysm market.
North American region is the most dominant region for the intracranial aneurysm market in 2022 with a market share of 27.2% of the global market.
1. Executive Summary | Intracranial Aneurysm Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Surgical Clipping 5.3.2. Endovascular Coiling 5.3.3. Flow Diverters 5.3.4. Other Types 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2022 to 2032 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Others 6.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By End-use 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By End-use 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End-use 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Type 10.2.3. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End-use 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. India 11.2.1.5. Malaysia 11.2.1.6. Singapore 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia-Pacific 11.2.2. By Type 11.2.3. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End-use 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Type 12.2.3. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End-use 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United States of America 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Type 13.1.2.2. By End-use 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Type 13.2.2.2. By End-use 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Type 13.3.2.2. By End-use 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Type 13.4.2.2. By End-use 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Type 13.5.2.2. By End-use 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Type 13.6.2.2. By End-use 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Type 13.7.2.2. By End-use 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Type 13.8.2.2. By End-use 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Type 13.9.2.2. By End-use 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Type 13.10.2.2. By End-use 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Type 13.11.2.2. By End-use 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Type 13.12.2.2. By End-use 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Type 13.13.2.2. By End-use 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Type 13.14.2.2. By End-use 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Type 13.15.2.2. By End-use 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Type 13.16.2.2. By End-use 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Type 13.17.2.2. By End-use 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Type 13.18.2.2. By End-use 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Type 13.19.2.2. By End-use 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Type 14.3.3. By End-use 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Medtronic 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. MicroPort Scientific Corporation 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. B. Braun 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Stryker 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Johnson and Johnson Services Inc. 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Microvention Inc. 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Integra LifeSciences 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Sim & Cure 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Oxford Endovascular 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. Spartan Micro, Inc. 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.11. Zylox-Tonbridge Medical Technology Co., Ltd 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 15.1.12. Mizuho Medical Co.Ltd. 15.1.12.1. Overview 15.1.12.2. Product Portfolio 15.1.12.3. Profitability by Market Segments 15.1.12.4. Sales Footprint 15.1.12.5. Strategy Overview 15.1.12.5.1. Marketing Strategy 15.1.13. Lepu Medical Technology (Beijing)Co., Ltd. 15.1.13.1. Overview 15.1.13.2. Product Portfolio 15.1.13.3. Profitability by Market Segments 15.1.13.4. Sales Footprint 15.1.13.5. Strategy Overview 15.1.13.5.1. Marketing Strategy 15.1.14. Phenox GmbH 15.1.14.1. Overview 15.1.14.2. Product Portfolio 15.1.14.3. Profitability by Market Segments 15.1.14.4. Sales Footprint 15.1.14.5. Strategy Overview 15.1.14.5.1. Marketing Strategy 15.1.15. Peter Lazic GmbH 15.1.15.1. Overview 15.1.15.2. Product Portfolio 15.1.15.3. Profitability by Market Segments 15.1.15.4. Sales Footprint 15.1.15.5. Strategy Overview 15.1.15.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032 Table 2: Global Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 3: Global Market Value (US$ Million) Forecast by End-use, 2017 to 2032 Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 5: North America Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 6: North America Market Value (US$ Million) Forecast by End-use, 2017 to 2032 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 9: Latin America Market Value (US$ Million) Forecast by End-use, 2017 to 2032 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 11: Europe Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 12: Europe Market Value (US$ Million) Forecast by End-use, 2017 to 2032 Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 14: Asia Pacific Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 15: Asia Pacific Market Value (US$ Million) Forecast by End-use, 2017 to 2032 Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032 Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2017 to 2032 Table 18: Middle East and Africa Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Figure 1: Global Market Value (US$ Million) by Type, 2022 to 2032 Figure 2: Global Market Value (US$ Million) by End-use, 2022 to 2032 Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032 Figure 7: Global Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 10: Global Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 11: Global Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 12: Global Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 13: Global Market Attractiveness by Type, 2022 to 2032 Figure 14: Global Market Attractiveness by End-use, 2022 to 2032 Figure 15: Global Market Attractiveness by Region, 2022 to 2032 Figure 16: North America Market Value (US$ Million) by Type, 2022 to 2032 Figure 17: North America Market Value (US$ Million) by End-use, 2022 to 2032 Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 22: North America Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 25: North America Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 26: North America Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 27: North America Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 28: North America Market Attractiveness by Type, 2022 to 2032 Figure 29: North America Market Attractiveness by End-use, 2022 to 2032 Figure 30: North America Market Attractiveness by Country, 2022 to 2032 Figure 31: Latin America Market Value (US$ Million) by Type, 2022 to 2032 Figure 32: Latin America Market Value (US$ Million) by End-use, 2022 to 2032 Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 40: Latin America Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 43: Latin America Market Attractiveness by Type, 2022 to 2032 Figure 44: Latin America Market Attractiveness by End-use, 2022 to 2032 Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032 Figure 46: Europe Market Value (US$ Million) by Type, 2022 to 2032 Figure 47: Europe Market Value (US$ Million) by End-use, 2022 to 2032 Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 52: Europe Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 55: Europe Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 56: Europe Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 58: Europe Market Attractiveness by Type, 2022 to 2032 Figure 59: Europe Market Attractiveness by End-use, 2022 to 2032 Figure 60: Europe Market Attractiveness by Country, 2022 to 2032 Figure 61: Asia Pacific Market Value (US$ Million) by Type, 2022 to 2032 Figure 62: Asia Pacific Market Value (US$ Million) by End-use, 2022 to 2032 Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032 Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 70: Asia Pacific Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 73: Asia Pacific Market Attractiveness by Type, 2022 to 2032 Figure 74: Asia Pacific Market Attractiveness by End-use, 2022 to 2032 Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032 Figure 76: Middle East and Africa Market Value (US$ Million) by Type, 2022 to 2032 Figure 77: Middle East and Africa Market Value (US$ Million) by End-use, 2022 to 2032 Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032 Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032 Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032 Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032 Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2017 to 2032 Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2022 to 2032 Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032 Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by End-use, 2017 to 2032 Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032 Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032 Figure 88: Middle East and Africa Market Attractiveness by Type, 2022 to 2032 Figure 89: Middle East and Africa Market Attractiveness by End-use, 2022 to 2032 Figure 90: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
Recommendations
Explore Healthcare Insights
View Reports